Matthew Emil Pasto, MD
Diagnostic Radiology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 20
- 5 carriers
- Office
- 1
- Since medical school
- 51 years
- Graduated 1975
Offices
1 location · Bay Imaging Consultants Medical Group Inc · 133 clinicians in this group
Hospitals listed: Good Samaritan Hospital · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
20 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Pasto’s office at (925) 296-7150 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
20 of 20 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$143,846
Medicare paid this office $143,846 for 1,915 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Screening mammography | 1,115 | $48,697 | $44 |
| Screening 3d breast mammography | 1,108 | $38,005 | $34 |
| Complete ultrasound scan of 1 breast | 328 | $13,510 | $40 |
| Dxa bone density measurement of hip, pelvis, spine | 725 | $8,276 | $11 |
| Mri scan of both breasts | 69 | $7,162 | $101 |
See all 13 services
| Screening mammography | 1,115 | $48,697 | $44 |
| Screening 3d breast mammography | 1,108 | $38,005 | $34 |
| Complete ultrasound scan of 1 breast | 328 | $13,510 | $40 |
| Dxa bone density measurement of hip, pelvis, spine | 725 | $8,276 | $11 |
| Mri scan of both breasts | 69 | $7,162 | $101 |
| Diagnostic mammography of 1 breast | 190 | $7,154 | $34 |
| Diagnostic mammography of both breasts | 100 | $4,073 | $40 |
| Limited ultrasound scan of 1 breast | 114 | $3,727 | $31 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 26 | $3,619 | $139 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 115 | $2,964 | $24 |
| Biopsy of breast and placement of locating device using x-ray with needle, first growth | 15 | $2,302 | $153 |
| Dxa bone density measurement of forearm, finger, hand, or foot | 160 | $1,827 | $11 |
| X-ray of surgical specimen | 12 | $191 | $15 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Biopsy of breast and placement of locating device using ultrasound, first growth | 34 | 31 | 18 | 28 | 36 | 26 |
| Biopsy of breast and placement of locating device using x-ray with needle, first growth | – | – | – | – | – | 15 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
1,915 Original Medicare patients in 2024. Average age 75 · Under 65 1% · 85 and older 8% · Also on Medicaid 4% · Health risk score 0.77. At or below the middle of the specialty; the typical diagnostic radiology clinician is at 1.7.
Conditions among them: High blood pressure 63% · Cancer 22% · Diabetes 20% · Coronary heart disease 16% · Depression 13% · Atrial fibrillation 11% · Chronic kidney disease 10% · Heart failure 6% · COPD 6% · Stroke 5% · Dementia 2%.
The office billed $627,568, Medicare allowed $159,879 and paid $143,846; for 4,163 services of 26 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,915 | 4,163 | 75 | 0.77 | $627,568 | $143,846 |
| 2023 | 1,774 | 3,924 | 75 | 0.78 | $592,259 | $132,402 |
| 2022 | 1,492 | 3,222 | 75 | 0.75 | $459,763 | $113,781 |
| 2021 | 1,618 | 3,412 | 74 | 0.75 | $462,864 | $124,051 |
| 2020 | 1,389 | 2,917 | 74 | 0.81 | $373,236 | $105,881 |
| 2019 | 2,139 | 4,696 | 75 | 0.87 | $551,076 | $172,036 |
| 2018 | 2,437 | 5,161 | 75 | 0.97 | $558,063 | $172,876 |
| 2017 | 2,176 | 4,502 | 74 | 0.88 | $489,939 | $149,486 |
| 2016 | 2,637 | 6,674 | 75 | 1.06 | $535,391 | $155,337 |
| 2015 | 2,600 | 6,362 | 74 | 0.94 | $557,257 | $150,800 |
| 2014 | 2,719 | 5,615 | 75 | 0.93 | $477,451 | $114,712 |
| 2013 | 2,205 | 4,761 | 74 | 0.83 | $422,675 | $96,104 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Screening mammography | 1,087 | $45,002 | $41 |
| Screening 3d breast mammography | 1,082 | $35,425 | $33 |
| Complete ultrasound scan of 1 breast | 328 | $13,193 | $40 |
| Diagnostic mammography of 1 breast | 190 | $7,147 | $34 |
| Mri scan of both breasts | 69 | $6,869 | $98 |
| Dxa bone density measurement of hip, pelvis, spine | 627 | $6,699 | $11 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 36 | $4,823 | $134 |
| Diagnostic mammography of both breasts | 77 | $3,248 | $42 |
| Limited ultrasound scan of 1 breast | 87 | $2,722 | $30 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 81 | $2,096 | $26 |
| Dxa bone density measurement of forearm, finger, hand, or foot | 182 | $2,035 | $11 |
2022: 20 services
| Screening mammography | 634 | $26,560 | $42 |
| Screening 3d breast mammography | 584 | $19,626 | $33 |
| Screening mammography | 323 | $13,508 | $42 |
| Screening 3d breast mammography | 316 | $10,574 | $33 |
| Mri scan of both breasts | 64 | $6,330 | $94 |
| Limited ultrasound scan of 1 breast | 198 | $5,989 | $30 |
| Complete ultrasound scan of 1 breast | 98 | $4,127 | $42 |
| Diagnostic mammography of 1 breast | 98 | $3,322 | $31 |
| Complete ultrasound scan of 1 breast | 79 | $2,722 | $34 |
| Dxa bone density measurement of hip, pelvis, spine | 236 | $2,606 | $11 |
| Diagnostic mammography of 1 breast | 66 | $2,476 | $35 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 17 | $2,256 | $133 |
| Diagnostic mammography of both breasts | 40 | $1,719 | $42 |
| Dxa bone density measurement of hip, pelvis, spine | 156 | $1,708 | $11 |
| Diagnostic mammography of both breasts | 47 | $1,679 | $35 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 11 | $1,426 | $130 |
| Limited ultrasound scan of 1 breast | 42 | $1,331 | $32 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 65 | $1,318 | $20 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 45 | $1,177 | $26 |
| Dxa bone density measurement of forearm, finger, hand, or foot | 33 | $377 | $11 |
2021: 15 services
| Screening mammography | 984 | $42,452 | $43 |
| Screening 3d breast mammography | 917 | $31,353 | $34 |
| Limited ultrasound scan of 1 breast | 317 | $12,173 | $37 |
| Mri scan of both breasts | 68 | $6,654 | $98 |
| Dxa bone density measurement of hip, pelvis, spine | 442 | $4,944 | $11 |
| Diagnostic mammography of 1 breast | 105 | $3,878 | $34 |
| Diagnostic mammography of both breasts | 75 | $3,404 | $45 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 118 | $3,221 | $26 |
| Screening mammography | 72 | $3,131 | $43 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 18 | $2,531 | $141 |
| Screening 3d breast mammography | 72 | $2,478 | $34 |
| Complete ultrasound scan of 1 breast | 43 | $2,033 | $47 |
| Dxa bone density measurement of hip, pelvis, spine | 31 | $349 | $11 |
| Limited ultrasound scan of 1 breast | 11 | $327 | $30 |
| X-ray of surgical specimen | 18 | $275 | $14 |
2020: 11 services
| Screening mammography | 872 | $38,399 | $44 |
| Screening 3d breast mammography | 796 | $27,403 | $34 |
| Complete ultrasound scan of 1 breast | 164 | $6,239 | $38 |
| Mri scan of both breasts | 56 | $5,872 | $101 |
| Limited ultrasound scan of 1 breast | 154 | $5,592 | $35 |
| Diagnostic mammography of 1 breast | 131 | $4,873 | $32 |
| Dxa bone density measurement of hip, pelvis, spine | 408 | $4,628 | $11 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 31 | $4,092 | $132 |
| Diagnostic mammography of both breasts | 60 | $2,548 | $42 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 85 | $2,013 | $23 |
| X-ray of chest, 2 views | 33 | $251 | $7 |
2019: 14 services
| Screening mammography | 1,329 | $57,002 | $43 |
| Screening 3d breast mammography | 1,200 | $40,532 | $34 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 34 | $12,127 | $357 |
| Complete ultrasound scan of 1 breast | 250 | $12,083 | $33 |
| Diagnostic mammography of 1 breast | 196 | $7,500 | $33 |
| Mri scan of both breasts | 74 | $7,485 | $100 |
| Limited ultrasound scan of 1 breast | 206 | $7,323 | $28 |
| Dxa bone density measurement of hip, pelvis, spine | 652 | $7,241 | $11 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 130 | $3,653 | $27 |
| Diagnostic mammography of both breasts | 89 | $3,606 | $40 |
| X-ray of chest, 2 views | 71 | $601 | $8 |
| X-ray of surgical specimen | 23 | $183 | $7 |
| X-ray of lower and sacral spine, minimum of 4 views | 11 | $143 | $13 |
| X-ray of shoulder, minimum of 2 views | 12 | $87 | $7 |
2018: 23 services
| Screening mammography | 1,340 | $57,523 | $43 |
| Screening 3d breast mammography | 1,191 | $40,282 | $34 |
| Complete ultrasound scan of 1 breast | 240 | $12,085 | $29 |
| Screening mammography | 202 | $8,678 | $43 |
| Diagnostic mammography of 1 breast | 193 | $6,926 | $32 |
| Screening 3d breast mammography | 184 | $6,228 | $34 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 39 | $5,429 | $139 |
| Dxa bone density measurement of hip, pelvis, spine | 438 | $5,081 | $12 |
| Limited ultrasound scan of 1 breast | 148 | $4,765 | $27 |
| MRI scan of both breasts with contrast | 59 | $4,189 | $66 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 73 | $1,950 | $26 |
| Diagnostic mammography of both breasts | 49 | $1,775 | $35 |
| Complete ultrasound scan of 1 breast | 33 | $1,720 | $33 |
| Limited ultrasound scan of 1 breast | 41 | $1,620 | $31 |
| Diagnostic mammography of 1 breast | 41 | $1,618 | $37 |
| X-ray of chest, 2 views | 121 | $1,034 | $8 |
| Dxa bone density measurement of hip, pelvis, spine | 85 | $986 | $12 |
| Diagnostic mammography of both breasts | 19 | $862 | $43 |
| Placement of locating device in breast using ultrasound guidance, first growth | 11 | $857 | $78 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 31 | $839 | $27 |
| X-ray of chest, 1 view | 76 | $663 | $8 |
| X-ray of surgical specimen | 19 | $146 | $7 |
| X-ray of knee, 3 views | 14 | $130 | $7 |
2017: 18 services
| Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed | 1,410 | $58,366 | $41 |
| Screening 3d breast mammography | 1,167 | $39,967 | $34 |
| Complete ultrasound scan of 1 breast | 197 | $9,204 | $29 |
| Diagnostic mammography, including computer-aided detection (cad) when performed; unilateral | 219 | $7,790 | $31 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 48 | $6,811 | $139 |
| Limited ultrasound scan of 1 breast | 197 | $6,311 | $27 |
| Dxa bone density measurement of hip, pelvis, spine | 454 | $5,254 | $12 |
| MRI scan of both breasts with contrast | 63 | $4,468 | $69 |
| Diagnostic mammography, including computer-aided detection (cad) when performed; bilateral | 63 | $2,342 | $37 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 79 | $1,966 | $24 |
| Biopsy of breast and placement of locating device using x-ray with needle, first growth | 11 | $1,515 | $138 |
| X-ray of chest, 2 views, front and side | 124 | $1,176 | $9 |
| X-ray of lower and sacral spine, minimum of 4 views | 16 | $200 | $12 |
| X-ray of chest, 1 view, front | 18 | $149 | $8 |
| X-ray of surgical specimen | 18 | $138 | $7 |
| X-ray of hip, 2-3 views | 13 | $133 | $10 |
| X-ray of knee, 3 views | 15 | $112 | $7 |
| X-ray of shoulder, minimum of 2 views | 11 | $61 | $6 |
2016: 31 services
| Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed | 1,381 | $53,976 | $39 |
| Screening 3d breast mammography | 1,013 | $34,212 | $34 |
| Limited ultrasound scan of 1 breast | 270 | $9,431 | $27 |
| Diagnostic mammography, including computer-aided detection (cad) when performed; unilateral | 252 | $8,027 | $27 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 49 | $6,716 | $134 |
| Dxa bone density measurement of hip, pelvis, spine | 453 | $5,233 | $12 |
| Complete ultrasound scan of 1 breast | 83 | $4,644 | $32 |
| Computer analysis of screening mammogram to assist detection of cancer | 1,380 | $4,454 | $3 |
| MRI scan of both breasts with contrast | 53 | $3,423 | $63 |
| X-ray of chest, 2 views, front and side | 247 | $2,465 | $9 |
| Diagnostic mammography, including computer-aided detection (cad) when performed; bilateral | 74 | $2,450 | $33 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 78 | $2,059 | $25 |
| X-ray of chest, 1 view, front | 194 | $1,836 | $8 |
| Biopsy of breast and placement of locating device using x-ray with needle, first growth | 11 | $1,487 | $135 |
| Ct scan of abdomen and pelvis with contrast | 17 | $1,402 | $82 |
| Ct scan of abdomen and pelvis without contrast | 17 | $1,292 | $76 |
| Placement of locating device in breast using ultrasound guidance, first growth | 11 | $855 | $78 |
| Ct scan head or brain without contrast | 23 | $830 | $36 |
| Computer analysis of diagnostic mammogram | 276 | $642 | $2 |
| X-ray of lower and sacral spine, minimum of 4 views | 31 | $427 | $14 |
| X-ray of knee, 3 views | 31 | $268 | $8 |
| X-ray of lower and sacral spine, 2-3 views | 30 | $265 | $9 |
| X-ray of hip, 2-3 views | 24 | $245 | $10 |
| X-ray of shoulder, minimum of 2 views | 23 | $181 | $7 |
| X-ray of pelvis, 1-2 views | 23 | $175 | $7 |
| X-ray of hip, 1 view | 20 | $163 | $8 |
| X-ray of ribs on side of body, 2 views | 15 | $154 | $10 |
| X-ray of surgical specimen | 20 | $152 | $7 |
| X-ray of hand, minimum of 3 views | 17 | $151 | $7 |
| X-ray of knee, 4 or more views | 11 | $133 | $10 |
| X-ray of foot, minimum of 3 views | 14 | $106 | $8 |
2015: 27 services
| Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed | 1,584 | $61,960 | $39 |
| Screening 3d breast mammography | 851 | $28,745 | $34 |
| Limited ultrasound scan of 1 breast | 325 | $12,513 | $28 |
| Diagnostic mammography, including computer-aided detection (cad) when performed; unilateral | 284 | $8,772 | $27 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 52 | $7,757 | $146 |
| Computer analysis of screening mammogram to assist detection of cancer | 1,404 | $4,750 | $3 |
| Dxa bone density measurement of hip, pelvis, spine | 396 | $4,554 | $11 |
| MRI scan of both breasts with contrast | 50 | $3,418 | $68 |
| Diagnostic mammography, including computer-aided detection (cad) when performed; bilateral | 76 | $2,759 | $36 |
| Biopsy of breast and placement of locating device using x-ray with needle, first growth | 13 | $2,112 | $151 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 74 | $1,992 | $26 |
| X-ray of chest, 2 views, front and side | 202 | $1,721 | $8 |
| Placement of locating device in breast using ultrasound guidance, first growth | 18 | $1,413 | $78 |
| Review by radiologist of image from tube placement into bile and pancreatic duct using an endoscope | 16 | $789 | $42 |
| Biopsy of breast and placement of locating device using ultrasound, each additional growth | 11 | $783 | $71 |
| Computer analysis of diagnostic mammogram | 297 | $729 | $2 |
| X-ray of chest, 1 view, front | 86 | $582 | $6 |
| X-ray of lower and sacral spine, 2-3 views | 21 | $207 | $10 |
| X-ray of surgical specimen | 24 | $207 | $7 |
| Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | 17 | $180 | $11 |
| X-ray of pelvis, 1-2 views | 27 | $170 | $6 |
| X-ray of lower and sacral spine, minimum of 4 views | 13 | $158 | $12 |
| X-ray of shoulder, minimum of 2 views | 20 | $140 | $6 |
| X-ray of ribs on side of body, minimum of 3 views | 13 | $134 | $10 |
| X-ray of knee, 3 views | 15 | $105 | $6 |
| Computer-aided detection and computer algorithm analysis of breast MRI image data | 27 | $68 | $3 |
| X-ray of hip on one side of body, 1 view | 12 | $65 | $5 |
2014: 28 services
| Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed | 1,631 | $63,590 | $39 |
| Diagnostic mammography, including computer-aided detection (cad) when performed; unilateral | 275 | $8,077 | $27 |
| Ultrasound of breasts | 302 | $6,389 | $21 |
| Biopsy of breast and placement of locating device using ultrasound, first growth | 43 | $6,052 | $141 |
| Computer analysis of screening mammogram to assist detection of cancer | 1,629 | $5,515 | $3 |
| Dxa bone density measurement of hip, pelvis, spine | 342 | $3,925 | $11 |
| MRI scan of both breasts with contrast | 42 | $2,719 | $65 |
| Diagnostic mammography, including computer-aided detection (cad) when performed; bilateral | 74 | $2,401 | $32 |
| Biopsy of breast and placement of locating device using x-ray with needle, first growth | 14 | $2,080 | $149 |
| X-ray of chest, 1 view, front | 178 | $1,642 | $8 |
| X-ray of chest, 2 views, front and side | 149 | $1,360 | $9 |
| Placement of locating device in breast using ultrasound guidance, first growth | 13 | $979 | $75 |
| Review by radiologist of image from tube placement into bile and pancreatic duct using an endoscope | 21 | $913 | $41 |
| Computer analysis of diagnostic mammogram | 298 | $709 | $2 |
| Ct scan head or brain without contrast | 15 | $480 | $32 |
| X-ray of lower and sacral spine, minimum of 4 views | 21 | $258 | $12 |
| X-ray of hip during surgery | 16 | $214 | $13 |
| X-ray of pelvis, 1-2 views | 28 | $205 | $7 |
| X-ray of knee, 3 views | 20 | $204 | $9 |
| Imaging of abdomen | 15 | $194 | $12 |
| X-ray of surgical specimen | 23 | $183 | $7 |
| Spine scanning X-ray done with bone density measurement for spine compression | 25 | $175 | $7 |
| X-ray of shoulder, minimum of 2 views | 16 | $169 | $9 |
| X-ray of lower and sacral spine, 2-3 views | 18 | $168 | $9 |
| X-ray of hip on one side of body, 1 view | 17 | $131 | $8 |
| X-ray of foot, minimum of 3 views | 15 | $129 | $8 |
| X-ray of abdomen, single view | 12 | $116 | $8 |
| Computer-aided detection and computer algorithm analysis of breast MRI image data | 41 | $105 | $3 |
2013: 20 services
| Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed | 1,508 | $57,797 | $38 |
| Diagnostic mammography, including computer-aided detection (cad) when performed; unilateral | 248 | $7,105 | $27 |
| Computer analysis of screening mammogram to assist detection of cancer | 1,506 | $4,849 | $3 |
| Ultrasound of breasts | 187 | $4,087 | $21 |
| MRI scan of both breasts with contrast | 51 | $3,402 | $67 |
| Biopsy of breast using imaging guidance | 32 | $3,073 | $77 |
| Dxa bone density measurement of hip, pelvis, spine | 248 | $2,713 | $11 |
| Diagnostic mammography, including computer-aided detection (cad) when performed; bilateral | 80 | $2,515 | $31 |
| Biopsy of breast using imaging guidance | 14 | $2,224 | $159 |
| Presurgical insertion of needle wire to localize breast growth | 26 | $1,429 | $55 |
| X-ray of chest, 2 views, front and side | 154 | $1,363 | $8 |
| Ultrasonic guidance for needle placement | 43 | $1,299 | $28 |
| Radiological supervision and interpretation of imaging guidance for breast biopsy or insertion of needle | 11 | $672 | $61 |
| Computer analysis of diagnostic mammogram | 286 | $669 | $2 |
| Radiological supervision and interpretation of imaging guidance of breast for insertion of needle | 17 | $405 | $24 |
| X-ray of surgical specimen | 35 | $271 | $7 |
| Computer-aided detection and computer algorithm analysis of breast MRI image data | 51 | $141 | $3 |
| X-ray of pelvis, 1-2 views | 20 | $125 | $6 |
| X-ray of hip on one side of body, 1 view | 15 | $90 | $6 |
| Spine scanning X-ray done with bone density measurement for spine compression | 12 | $83 | $7 |
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 13 Part D prescriptions in 2022. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2022 | 13 | None | 0% (0) | 0% | $766 |
| 2021 | 16 | None | 0% (0) | None | $756 |
| 2020 | 23 | None | 0% (0) | None | $3,453 |
| 2019 | 24 | None | 0% (0) | None | $4,292 |
| 2018 | 20 | None | 0% (0) | None | $617 |
| 2017 | 29 | None | 0% (0) | None | $241 |
| 2016 | 36 | None | 0% (0) | None | $314 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2017: 1 drug
| Sulfamethoxazole-Trimethoprim | 13 | $18 | $1 |
2016: 1 drug
| Pantoprazole | 12 | $22 | $2 |
Money from drug and device companies
$69 in 2022
| 2022 | 1 | 3 | None | $69 |
| 2019 | 1 | 1 | None | $25 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Leica Microsystems | Hydromark Breast Biopsy Site Marker | $69 | 3 payments
|
See all 3 published payments
| Leica Microsystems | Meals · 2022-12-15 | Hydromark Breast Biopsy Site Marker | $17 |
| Leica Microsystems | Meals · 2022-02-17 | Hydromark Breast Biopsy Site Marker | $26 |
| Leica Microsystems | Meals · 2022-02-03 | Hydromark Breast Biopsy Site Marker | $26 |
See earlier years (2019)
2019: $25
| Rigel Pharmaceuticals | Tavalisse | $25 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 90.8 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1841297272
- Licence
- CA A031256
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- PA 000793222
- Taxonomy
- Diagnostic radiology (2085R0202X)
- Mailing address
- Radiological Associates Medical Group, 2410 Samaritan Dr., Suite 101, San Jose, CA, 95124
- NPI first listed
- 2005-06-30
- NPI last updated
- 2020-12-04
- NPI record certified
- 2020-12-04
This is when the NPI record was last certified, not a medical board exam.